Akinyelure, Oluwasegun P.
Colvin, Calvin L.
Sterling, Madeline R.
Safford, Monika M.
Muntner, Paul
Colantonio, Lisandro D.
Kern, Lisa M.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01 HL135199)
Article History
Received: 1 November 2021
Accepted: 16 May 2022
First Online: 2 June 2022
Declarations
:
: The REGARDS study was approved by the institutional review boards of the participating centers. The current analysis was approved by the institutional review board at the University of Alabama at Birmingham. All participants provided written informed consent. This study meets the ethical requirement of the Declaration of Helsinki. All methods were carried out in accordance with the ethical approval of the Institutional review board at the University of Alabama at Birmingham.
: Not applicable.
: Drs. Colantonio, Safford and Muntner receive research support from Amgen, Inc., unrelated to the submitted work. Dr. Muntner is a consultant to Amgen, Inc., unrelated to the submitted work. Dr. Kern is a consultant to Mathematica, Inc., unrelated to the submitted work. The other authors declare no competing interests.